Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | BIRB 0796 | FIMM | pan-cancer | AAC | -0.069 | 0.7 |
mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | GSK4112 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | etoposide | GDSC1000 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | JNK-9L | GDSC1000 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | BRD-K85133207 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | BRD-K29313308 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |